SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HARRISON THOMAS L

(Last) (First) (Middle)
1100 PARK PLACE
SUITE 300

(Street)
SAN MATEO CA 94403

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EPOCRATES INC [ EPOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/12/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $1.21 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $4.29 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $5.5 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $13.26 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $12.11 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $10.17 03/12/2013 D 10,479 (1) (2) Common Stock 10,479 (2) 0 D
Non-Qualified Stock Option (right to buy) $13.36 03/12/2013 D 15,720 (1) (2) Common Stock 15,720 (2) 0 D
Non-Qualified Stock Option (right to buy) $21.98 03/12/2013 D 11,790 (1) (2) Common Stock 11,790 (2) 0 D
Non-Qualified Stock Option (right to buy) $8.14 03/12/2013 D 11,790 (3) (2) Common Stock 11,790 (2) 0 D
Explanation of Responses:
1. The stock options under this award were fully vested prior to the closing of the Merger (as defined below).
2. Pursuant to the Agreement and Plan of Merger among Epocrates, Inc. (the Issuer), athenahealth, Inc., and Echo Merger Sub, Inc., a wholly-owned subsidiary of athenahealth, Inc., dated January 7, 2013 (the Merger Agreement), each share of the Issuer's common stock was exchanged for $11.75 in cash, without interest and less any applicable withholding taxes (the Merger). In connection with the Merger, the vested and/or exercisable portion of each Issuer stock option held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of the number of shares issuable upon the exercise of such option and $11.75 minus the exercise price of such option. The Reporting Person's options, if any, with an exercise price equal to or above $11.75 were canceled in connection with the Merger.
3. 5,895 of the stock options under this award were vested prior to the closing of the Merger. 5,895 of the stock options under this award accelerated and became fully vested as of the closing of the Merger.
/s/ Matthew B. Hemington, Attorney-in-Fact for Thomas L. Harrison 03/13/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.